2016 ESMO临床诊疗指南:胃癌的诊断、治疗与随访

2016-09-20 欧洲肿瘤内科学会 Ann Oncol. 2016 Sep;27(suppl 5):v38-v49.

2016年9月,欧洲肿瘤内科学会(ESMO)发布了胃癌的诊断、治疗与随访指南,指南主要内容包括:发病率和流行病学,诊断以及病理,分期和风险评估,治疗计划,各种类型疾病的治疗,个体化医疗和靶向治疗,监测和随访等。

中文标题:

2016 ESMO临床诊疗指南:胃癌的诊断、治疗与随访

英文标题:

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

发布机构:

欧洲肿瘤内科学会

发布日期:

2016-09-20

简要介绍:

2016年9月,欧洲肿瘤内科学会(ESMO)发布了胃癌的诊断、治疗与随访指南,指南主要内容包括:发病率和流行病学,诊断以及病理,分期和风险评估,治疗计划,各种类型疾病的治疗,个体化医疗和靶向治疗,监测和随访等。

相关资料下载:
[AttachmentFileName(sort=100, fileName=2016 ESMO临床诊疗指南:胃癌的诊断、治疗与随访)] GetToolGuiderByIdResponse(projectId=1, id=a89491c0012915ba, title=2016 ESMO临床诊疗指南:胃癌的诊断、治疗与随访, enTitle=Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up., guiderFrom=Ann Oncol. 2016 Sep;27(suppl 5):v38-v49., authorId=null, author=, summary=2016年9月,欧洲肿瘤内科学会(ESMO)发布了胃癌的诊断、治疗与随访指南,指南主要内容包括:发病率和流行病学,诊断以及病理,分期和风险评估,治疗计划,各种类型疾病的治疗,个体化医疗和靶向治疗,监测和随访等。, cover=, journalId=null, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology )是1975年成立的非盈利组织,是欧洲领先的专业组织,致力于提高肿瘤内科的专业性,推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Tue Sep 20 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=2016年9月,欧洲肿瘤内科学会(ESMO)发布了胃癌的诊断、治疗与随访指南,指南主要内容包括:发病率和流行病学,诊断以及病理,分期和风险评估,治疗计划,各种类型疾病的治疗,个体化医疗和靶向治疗,监测和随访等。 <div><br> 拓展指南:<strong>与<font color=red>胃癌</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=e6a971c001283321" title="2016 腹腔镜胃癌手术操作指南" target=_blank>2016 腹腔镜胃癌手术操作指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=8be831c001281672" title="2015 阿帕替尼治疗胃癌的临床应用专家共识" target=_blank>2015 阿帕替尼治疗胃癌的临床应用专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c90de1c00125a9b1" title="2016 胃癌HER2检测指南(2016版)" target=_blank>2016 胃癌HER2检测指南(2016版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=5b0f11c001253e80" title="2016NCCN临床实践指南:胃癌(2016.V3)" target=_blank>2016NCCN临床实践指南:胃癌(2016.V3)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=386331c00123a0f9" title="2016 NCCN临床实践指南:胃癌(2016.V2)" target=_blank>2016 NCCN临床实践指南:胃癌(2016.V2)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%83%83%E7%99%8C" target=_blank>有关胃癌更多指南</a></ul></div>, tagList=[TagDto(tagId=438, tagName=胃癌)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7014, appHits=573, showAppHits=0, pcHits=5181, showPcHits=2063, likes=145, shares=13, comments=4, approvalStatus=1, publishedTime=Fri Sep 30 16:57:24 CST 2016, publishedTimeString=2016-09-20, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Fri Sep 30 16:57:24 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 17:26:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 ESMO临床诊疗指南:胃癌的诊断、治疗与随访)])
2016 ESMO临床诊疗指南:胃癌的诊断、治疗与随访
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=147015, encodeId=7cab14e0158d, content=为什么我下不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3b1651209, createdName=好小一只丫, createdTime=Wed Oct 12 16:26:26 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139729, encodeId=938f139e29d6, content=学习与更新很重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Tue Oct 04 06:38:06 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138471, encodeId=b78c1384e1d1, content=先下载,有时间再看。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ceb079804, createdName=lhl629, createdTime=Sat Oct 01 10:41:56 CST 2016, time=2016-10-01, status=1, ipAttribution=)]
    2016-10-12 好小一只丫

    为什么我下不了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=147015, encodeId=7cab14e0158d, content=为什么我下不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3b1651209, createdName=好小一只丫, createdTime=Wed Oct 12 16:26:26 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139729, encodeId=938f139e29d6, content=学习与更新很重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Tue Oct 04 06:38:06 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138471, encodeId=b78c1384e1d1, content=先下载,有时间再看。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ceb079804, createdName=lhl629, createdTime=Sat Oct 01 10:41:56 CST 2016, time=2016-10-01, status=1, ipAttribution=)]
    2016-10-04 1e0bc67dm33(暂无匿称)

    学习与更新很重要

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=147015, encodeId=7cab14e0158d, content=为什么我下不了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df3b1651209, createdName=好小一只丫, createdTime=Wed Oct 12 16:26:26 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139729, encodeId=938f139e29d6, content=学习与更新很重要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Tue Oct 04 06:38:06 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138471, encodeId=b78c1384e1d1, content=先下载,有时间再看。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ceb079804, createdName=lhl629, createdTime=Sat Oct 01 10:41:56 CST 2016, time=2016-10-01, status=1, ipAttribution=)]
    2016-10-01 lhl629

    先下载,有时间再看。

    0